Myomo (MYO) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2025)
Myomo (MYO) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 13.22% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 9.93% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 19.89% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 7.35% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 14.29% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 8.56% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 7.10% |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 1.61% |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | 66.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.38% |
| Sep 30, 2025 | 561.79% |
| Jun 30, 2025 | 905.45% |
| Mar 31, 2025 | 794.66% |
| Dec 31, 2024 | 656.57% |
| Sep 30, 2024 | 226.32% |
| Jun 30, 2024 | 88.20% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | -9.52% |
| Sep 30, 2023 | -28.31% |
| Jun 30, 2023 | -45.74% |
| Mar 31, 2023 | -31.77% |
| Dec 31, 2022 | -29.43% |
| Sep 30, 2022 | -20.57% |
| Jun 30, 2022 | -11.53% |
| Mar 31, 2022 | 32.93% |
| Dec 31, 2021 | 189.71% |
| Sep 30, 2021 | 186.12% |
| Jun 30, 2021 | 191.44% |
| Mar 31, 2021 | 51.07% |